FRONTIER CAPITAL MANAGEMENT CO LLC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 134 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2015. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.

Quarter-by-quarter ownership
FRONTIER CAPITAL MANAGEMENT CO LLC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2016$3,540,000
-67.5%
221,369
-41.8%
0.03%
-68.9%
Q4 2015$10,892,000
+42.2%
380,434
+41.3%
0.09%
+40.6%
Q3 2015$7,662,000
-24.5%
269,221
-4.7%
0.06%
-12.3%
Q2 2015$10,151,000
-50.8%
282,589
-20.4%
0.07%
-51.0%
Q1 2015$20,624,000
+107.8%
354,795
+50.7%
0.15%
+104.1%
Q4 2014$9,927,000235,4570.07%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q1 2015
NameSharesValueWeighting ↓
Orbimed Advisors 3,028,354$30,526,0000.37%
Engineers Gate Manager LP 96,105$969,0000.07%
BOOTHBAY FUND MANAGEMENT, LLC 61,600$621,0000.06%
GAM Holding AG 83,940$846,0000.03%
SHELL ASSET MANAGEMENT CO 90,282$910,0000.02%
SFMG, LLC 11,994$107,0000.02%
QS Investors, LLC 159,133$1,604,0000.02%
Winslow, Evans & Crocker, Inc. 4,060$42,0000.01%
PANAGORA ASSET MANAGEMENT INC 285,646$2,879,0000.01%
PEAK6 Investments LLC 225,800$2,276,0000.01%
View complete list of INSYS THERAPEUTICS INC NEW shareholders